Akebia Therapeutics (AKBA) Discloses $50M ATM Offering
Akebia Therapeutics (NASDAQ: AKBA) filed a prospectus supplement with the Securities and Exchange Commission that contemplates the sale of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
